These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 30152087)
21. Combinations of newly confirmed Glioma-Associated loci link regions on chromosomes 1 and 9 to increased disease risk. Yang TH; Kon M; Hung JH; Delisi C BMC Med Genomics; 2011 Aug; 4():63. PubMed ID: 21827660 [TBL] [Abstract][Full Text] [Related]
22. Genome-wide polygenic risk scores predict risk of glioma and molecular subtypes. Nakase T; Guerra GA; Ostrom QT; Ge T; Melin BS; Wrensch M; Wiencke JK; Jenkins RB; Eckel-Passow JE; ; Bondy ML; Francis SS; Kachuri L Neuro Oncol; 2024 Oct; 26(10):1933-1944. PubMed ID: 38916140 [TBL] [Abstract][Full Text] [Related]
24. Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells. Safaee M; Fakurnejad S; Bloch O; Clark AJ; Ivan ME; Sun MZ; Oh T; Phillips JJ; Parsa AT PLoS One; 2015; 10(2):e0111532. PubMed ID: 25714433 [TBL] [Abstract][Full Text] [Related]
25. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. Liang Y; Bollen AW; Aldape KD; Gupta N BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952 [TBL] [Abstract][Full Text] [Related]
26. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198 [TBL] [Abstract][Full Text] [Related]
27. A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma. Biterge-Sut B Arq Neuropsiquiatr; 2020 Jan; 78(1):34-38. PubMed ID: 32074192 [TBL] [Abstract][Full Text] [Related]
28. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Liu Q; Liu Y; Li W; Wang X; Sawaya R; Lang FF; Yung WK; Chen K; Fuller GN; Zhang W Acta Neuropathol; 2015 Oct; 130(4):587-97. PubMed ID: 26323991 [TBL] [Abstract][Full Text] [Related]
29. TP53 Mutation and Extraneural Metastasis of Glioblastoma: Insights From an Institutional Experience and Comprehensive Literature Review. Zhang X; Katsakhyan L; LiVolsi VA; Roth JJ; Rassekh CH; Bagley SJ; Nasrallah MP Am J Surg Pathol; 2021 Nov; 45(11):1516-1526. PubMed ID: 34366423 [TBL] [Abstract][Full Text] [Related]
30. Deciphering the 8q24.21 association for glioma. Enciso-Mora V; Hosking FJ; Kinnersley B; Wang Y; Shete S; Zelenika D; Broderick P; Idbaih A; Delattre JY; Hoang-Xuan K; Marie Y; Di Stefano AL; Labussière M; Dobbins S; Boisselier B; Ciccarino P; Rossetto M; Armstrong G; Liu Y; Gousias K; Schramm J; Lau C; Hepworth SJ; Strauch K; Müller-Nurasyid M; Schreiber S; Franke A; Moebus S; Eisele L; Forsti A; Hemminki K; Tomlinson IP; Swerdlow A; Lathrop M; Simon M; Bondy M; Sanson M; Houlston RS Hum Mol Genet; 2013 Jun; 22(11):2293-302. PubMed ID: 23399484 [TBL] [Abstract][Full Text] [Related]
32. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme. Khatri RG; Navaratne K; Weil RJ J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073 [TBL] [Abstract][Full Text] [Related]
33. CCDC26 gene polymorphism and glioblastoma risk in the Han Chinese population. Wei XB; Jin TB; Li G; Geng TT; Zhang JY; Chen CP; Gao GD; Chen C; Gong YK Asian Pac J Cancer Prev; 2014; 15(8):3629-33. PubMed ID: 24870769 [TBL] [Abstract][Full Text] [Related]
34. IDH1 mutation may not be prognostically favorable in glioblastoma when controlled for tumor location: A case-control study. Paldor I; Drummond KJ; Kaye AH J Clin Neurosci; 2016 Dec; 34():117-120. PubMed ID: 27522495 [TBL] [Abstract][Full Text] [Related]
35. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas. Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139 [TBL] [Abstract][Full Text] [Related]
36. ACTC1 as an invasion and prognosis marker in glioma. Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897 [TBL] [Abstract][Full Text] [Related]
37. Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts. Li D; Li S; Xue AZ; Smith Callahan LA; Liu Y Medicine (Baltimore); 2020 Mar; 99(12):e18815. PubMed ID: 32195924 [TBL] [Abstract][Full Text] [Related]
38. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients. Ferrer VP Cancer Genet; 2023 Jan; 270-271():22-30. PubMed ID: 36436416 [TBL] [Abstract][Full Text] [Related]
39. Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Olar A; Raghunathan A; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Goodman JC; Fuller GN Ann Diagn Pathol; 2012 Jun; 16(3):161-70. PubMed ID: 22197544 [TBL] [Abstract][Full Text] [Related]
40. BRAF mutations may identify a clinically distinct subset of glioblastoma. McNulty SN; Schwetye KE; Ferguson C; Storer CE; Ansstas G; Kim AH; Gutmann DH; Rubin JB; Head RD; Dahiya S Sci Rep; 2021 Oct; 11(1):19999. PubMed ID: 34625582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]